The British Business Bank has committed €25 million to EQT Life Sciences' EQT Health Economics 3 Fund, supporting high-potential life sciences companies in the UK. This investment is part of the Bank's ongoing efforts to back the UK's life sciences sector, one of the eight growth sectors of the UK Industrial Strategy. The fund will focus on commercial-stage, de-risked medtech and digital health technologies.

Sam Altman's public dismissal of 'space data centers' as a viable public market investment, aimed at Elon Musk, has ignited a crucial debate about the future of AI compute infrastructure. This 'trash talk,' validated by many experts, underscores the immense challenges and economic realities facing ambitious off-world computing visions. The exchange highlights a divergence in strategic thinking between two AI titans regarding where the industry's significant capital should be directed.

A European fertility group is advocating for international limits on sperm donations, citing the ethical dilemma of donor-conceived individuals discovering hundreds of siblings and the erosion of anonymity through consumer genetic testing services. This move underscores a growing challenge at the intersection of advanced reproductive technologies, vast genetic datasets, and evolving societal norms, demanding urgent policy and technological solutions.

Saltroad, a clinician‑led speech and language therapy provider, secured £1.5 million in funding and bought AI documentation platform Ogma to streamline therapy for children. The move aims to cut admin, standardise notes, and expand access across the UK.

Billions flood longevity research as scientists explore AI-driven cellular reprogramming to reverse aging. MIT’s Roundtable unpacks the science, funding, and ethical dilemmas behind this cutting-edge field.

Crunchbase data reveals Q2 2026 delivered the most billion‑dollar startup exits since 2021, led by SpaceX’s historic $75B IPO and a wave of high‑value acquisitions. While the count lags the 2021 peak, the sheer size of these deals is reshaping the AI and tech investment landscape.